Filing Details
- Accession Number:
- 0000899243-23-011217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-12 19:50:45
- Reporting Period:
- 2023-04-10
- Accepted Time:
- 2023-04-12 19:50:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216477 | E Todd Simpson | 21823 30Th Drive Se Bothell WA 98021 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-10 | 14,980 | $46.37 | 133,926 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-10 | 14,980 | $204.14 | 118,946 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-10 | 40,364 | $46.37 | 159,310 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-10 | 40,364 | $204.74 | 118,946 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-10 | 14,980 | $0.00 | 14,980 | $46.37 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-10 | 40,364 | $0.00 | 40,364 | $46.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,364 | 2027-08-17 | No | 4 | M | Direct | |
| 0 | 2027-08-17 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a written plan adopted on December 9, 2022 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- Reflects sales of common stock executed in multiple transactions at prices ranging from $203.49 to $204.48. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $204.49 to $205.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested 25% on 8/17/18 and monthly thereafter until all the options were fully vested on 8/17/21.
Billionaire Hedge Funds
